Clinical trial
Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer
NCT00008372 · City of Hope Medical Center, Other · Completed
Key facts
| NCT number | NCT00008372 |
|---|---|
| Title | Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer |
| Official title | Phase II Trial Of CQS (NSC 339004) In Platinum-Refractory Small Cell Lung Cancer |
| Lead sponsor | City of Hope Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | chloroquinoxaline sulfonamide |
| Start date | Dec 1, 2000 |
| Primary completion | Sep 1, 2002 |
| Completion | Sep 1, 2002 |
| First posted | Nov 11, 2003 |
| Last update posted | Oct 20, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: